RAS inhibitors vs CCBs
All‐cause death · patients with hypertension
RAS inhibitors showed no clear difference in all‐cause death compared with CCBs (moderate certainty).
1 finding from 1 review
- First‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for… 2018 · Cochrane Headline outcomes onlyRR 1.03 [0.98, 1.09]5 studies · 35226 participantsModerate